126 related articles for article (PubMed ID: 32875336)
1. Latent prostate cancer among Japanese males: a bibliometric study of autopsy reports from 1980-2016.
Takeshima Y; Suzuki M; Miyakawa J; Tsuru I; Yamada Y; Nakamura M; Sato Y; Kawai T; Yamada D; Morikawa T; Kume H
Jpn J Clin Oncol; 2021 Jan; 51(1):156-159. PubMed ID: 32875336
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
3. No change in the prevalence of latent prostate cancer over the last 10 years: a forensic autopsy study in Japan.
Hitosugi M; Mukaisho K; Kido M; Kamimura S; Furukawa S; Sugihara H
Biomed Res; 2017; 38(5):307-312. PubMed ID: 29070780
[TBL] [Abstract][Full Text] [Related]
4. Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study.
Kido M; Hitosugi M; Ishii K; Kamimura S; Joh K
Prostate; 2015 Jun; 75(9):917-22. PubMed ID: 25728717
[TBL] [Abstract][Full Text] [Related]
5. The frequency of latent prostatic carcinoma in young males: the Japanese experience.
Shiraishi T; Watanabe M; Matsuura H; Kusano I; Yatani R; Stemmermann GN
In Vivo; 1994; 8(3):445-7. PubMed ID: 7803732
[TBL] [Abstract][Full Text] [Related]
6. Forensic Autopsies can Determine Latent Prostate Cancer Prevalence.
Takaso M; Hitosugi M; Nakagawa R; Mukaisho K; Moriguchi S; Koh M; Sugihara H
J Forensic Sci; 2020 Sep; 65(5):1557-1562. PubMed ID: 32501618
[TBL] [Abstract][Full Text] [Related]
7. Time Trends in Histological Features of Latent Prostate Cancer in Japan.
Kimura T; Takahashi H; Okayasu M; Kido M; Inaba H; Kuruma H; Yamamoto T; Furusato B; Furusato M; Wada T; Egawa S
J Urol; 2016 May; 195(5):1415-1420. PubMed ID: 26678955
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study of latent carcinoma--with special reference to prostatic cancer].
Moriwaki S; Yamamoto Y; Takashima S; Uyama K; Higa I; Kanayama H
Gan No Rinsho; 1985 Jun; 31(7):847-53. PubMed ID: 2411968
[TBL] [Abstract][Full Text] [Related]
9. Possible underestimation of the incidence rate of prostate cancer in Japan.
Shimizu H; Ross RK; Bernstein L
Jpn J Cancer Res; 1991 May; 82(5):483-5. PubMed ID: 1905692
[TBL] [Abstract][Full Text] [Related]
10. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.
Siadat F; Sykes J; Zlotta AR; Aldaoud N; Egawa S; Pushkar D; Kuk C; Bristow RG; Montironi R; van der Kwast T
Prostate; 2015 Sep; 75(12):1277-84. PubMed ID: 25963383
[TBL] [Abstract][Full Text] [Related]
11. TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.
Maekawa S; Suzuki M; Arai T; Suzuki M; Kato M; Morikawa T; Kasuya Y; Kume H; Kitamura T; Homma Y
Int J Urol; 2014 Dec; 21(12):1234-8. PubMed ID: 25040002
[TBL] [Abstract][Full Text] [Related]
12. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986.
Yatani R; Shiraishi T; Nakakuki K; Kusano I; Takanari H; Hayashi T; Stemmermann GN
J Natl Cancer Inst; 1988 Jul; 80(9):683-7. PubMed ID: 3373558
[TBL] [Abstract][Full Text] [Related]
13. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening.
Humphrey PA; Keetch DW; Smith DS; Shepherd DL; Catalona WJ
J Urol; 1996 Mar; 155(3):816-20. PubMed ID: 8583583
[TBL] [Abstract][Full Text] [Related]
14. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
[TBL] [Abstract][Full Text] [Related]
15. An epidemiological survey of prostatic cancer from the Annual of the Pathological Autopsy Cases in Japan.
Araki H; Mishina T; Miyakoda K; Fujiwara T; Kobayashi T
Tohoku J Exp Med; 1980 Feb; 130(2):159-64. PubMed ID: 7385225
[TBL] [Abstract][Full Text] [Related]
16. [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan].
Nakata S; Ohtake N; Kubota Y; Ito K; Suzuki K; Yamanaka H;
Hinyokika Kiyo; 2004 Mar; 50(3):165-70. PubMed ID: 15148767
[TBL] [Abstract][Full Text] [Related]
17. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
18. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience.
Stemmermann GN; Nomura AM; Chyou PH; Yatani R
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):189-93. PubMed ID: 1306104
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of prostate cancer across the globe: what can autopsy studies teach us about this peculiar disease?
Zlotta AR; Kuk C
Arch Esp Urol; 2014 Jun; 67(5):400-8. PubMed ID: 24914839
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities.
Kubota Y; Ito K; Imai K; Yamanaka H
Prostate; 2002 Mar; 50(4):262-9. PubMed ID: 11870805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
